These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15794796

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M, Wallner K, True L, Cash J, Sorace R.
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.
    Mulhall JP, Levine LA, Jünemann KP.
    Urology; 2006 Sep 01; 68(3 Suppl):17-25. PubMed ID: 17011372
    [Abstract] [Full Text] [Related]

  • 34. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.
    Huyghe E, Delannes M, Wagner F, Delaunay B, Nohra J, Thoulouzan M, Shut-Yee JY, Plante P, Soulie M, Thonneau P, Bachaud JM.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):126-32. PubMed ID: 19362236
    [Abstract] [Full Text] [Related]

  • 35. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
    Davila HH, Weber T, Burday D, Thurman S, Carrion R, Salup R, Lockhart JL.
    BJU Int; 2007 Nov 01; 100(5):1026-9. PubMed ID: 17868423
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):956-64. PubMed ID: 15989995
    [Abstract] [Full Text] [Related]

  • 38. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ, Malcolm JB, Derweesh IH, Womack JH, Kincade MC, Mancini JG, Ogles ML, Lamar KD, Patterson AL, Wake RW.
    BJU Int; 2008 Jul 15; 102(1):39-43. PubMed ID: 18294309
    [Abstract] [Full Text] [Related]

  • 39. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
    Fang LC, Dattoli M, Taira A, True L, Sorace R, Wallner K.
    Urology; 2008 Jan 15; 71(1):146-50. PubMed ID: 18242384
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.